152 related articles for article (PubMed ID: 35839066)
21. Relevance of urinary S100B protein levels as a short-term prognostic biomarker in asphyxiated infants treated with hypothermia.
Alshweki A; Pérez-Muñuzuri A; López-Suárez O; Baña A; Couce ML
Medicine (Baltimore); 2017 Nov; 96(44):e8453. PubMed ID: 29095291
[TBL] [Abstract][Full Text] [Related]
22. S100B and NSE in Cluster Headache - Evidence for Glial Cell Activation?
Snoer AH; Vollesen ALH; Beske RP; Guo S; Hoffmann J; Jørgensen NR; Martinussen T; Ashina M; Jensen RH
Headache; 2020 Sep; 60(8):1569-1580. PubMed ID: 32548854
[TBL] [Abstract][Full Text] [Related]
23. The role of S100B protein, neuron-specific enolase, and glial fibrillary acidic protein in the evaluation of hypoxic brain injury in acute carbon monoxide poisoning.
Akdemir HU; Yardan T; Kati C; Duran L; Alacam H; Yavuz Y; Okuyucu A
Hum Exp Toxicol; 2014 Nov; 33(11):1113-20. PubMed ID: 24505052
[TBL] [Abstract][Full Text] [Related]
24. Elevated neuron-specific enolase and S100 calcium-binding protein B concentrations in cerebrospinal fluid of patients with anti-N-methyl-d-aspartate receptor encephalitis.
Liu B; Xie Z; Liu G; Gu Y; Pan S; Wang H
Clin Chim Acta; 2018 May; 480():79-83. PubMed ID: 29329729
[TBL] [Abstract][Full Text] [Related]
25. Serum S100β is a better biomarker than neuron-specific enolase for sepsis-associated encephalopathy and determining its prognosis: a prospective and observational study.
Yao B; Zhang LN; Ai YH; Liu ZY; Huang L
Neurochem Res; 2014 Jul; 39(7):1263-9. PubMed ID: 24760429
[TBL] [Abstract][Full Text] [Related]
26. Serum NSE and S100B protein levels for evaluating the impaired consciousness in patients with acute carbon monoxide poisoning.
Zhang L; Zhao J; Hao Q; Xu X; Han H; Li J
Medicine (Baltimore); 2021 Jun; 100(25):e26458. PubMed ID: 34160445
[TBL] [Abstract][Full Text] [Related]
27. A Pilot Study of the Use of Dexmedetomidine for the Control of Delirium by Reducing the Serum Concentrations of Brain-Derived Neurotrophic Factor, Neuron-Specific Enolase, and S100B in Polytrauma Patients.
Li Y; Yu ZX; Ji MS; Yan J; Cai Y; Liu J; Yang HF; Jin ZC
J Intensive Care Med; 2019 Aug; 34(8):674-681. PubMed ID: 28569132
[TBL] [Abstract][Full Text] [Related]
28. Brain injury markers: S100 calcium-binding protein B, neuron-specific enolase and glial fibrillary acidic protein in children with diabetic ketoacidosis.
Çatlı G; Anık A; Acar S; Küme T; Karabulut M; Çalan ÖG; Dündar BN; Abacı A
Pediatr Diabetes; 2018 Aug; 19(5):1000-1006. PubMed ID: 29484801
[TBL] [Abstract][Full Text] [Related]
29. Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children.
Berger RP; Pierce MC; Wisniewski SR; Adelson PD; Clark RS; Ruppel RA; Kochanek PM
Pediatrics; 2002 Feb; 109(2):E31. PubMed ID: 11826241
[TBL] [Abstract][Full Text] [Related]
30. The Value of the Biomarkers Neuron-Specific Enolase and S100 Calcium-Binding Protein for Prediction of Mortality in Children Resuscitated After Cardiac Arrest.
Bangshøj J; Liebetrau B; Wiberg S; Gjedsted J; Kjærgaard J; Hassager C; Wanscher M
Pediatr Cardiol; 2022 Oct; 43(7):1659-1665. PubMed ID: 35429240
[TBL] [Abstract][Full Text] [Related]
31. Serum levels of the S100B protein and neuron-specific enolase are associated with mortality in critically ill patients.
Duda I; Krzych Ł; Jędrzejowska-Szypułka H; Lewin-Kowalik J
Acta Biochim Pol; 2017; 64(4):647-652. PubMed ID: 29222857
[TBL] [Abstract][Full Text] [Related]
32. Neuron Specific Enolase, S100-beta protein and progranulin as diagnostic biomarkers of status epilepticus.
Hanin A; Denis JA; Frazzini V; Cousyn L; Imbert-Bismut F; Rucheton B; Bonnefont-Rousselot D; Marois C; Lambrecq V; Demeret S; Navarro V
J Neurol; 2022 Jul; 269(7):3752-3760. PubMed ID: 35190890
[TBL] [Abstract][Full Text] [Related]
33. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury.
Vos PE; Lamers KJ; Hendriks JC; van Haaren M; Beems T; Zimmerman C; van Geel W; de Reus H; Biert J; Verbeek MM
Neurology; 2004 Apr; 62(8):1303-10. PubMed ID: 15111666
[TBL] [Abstract][Full Text] [Related]
34. Serum S100B represents a biomarker for cognitive impairment in patients with end-stage renal disease.
Park BS; Lee HW; Lee YJ; Park S; Kim YW; Kim SE; Kim IH; Park JH; Park KM
Clin Neurol Neurosurg; 2020 Aug; 195():105902. PubMed ID: 32442806
[TBL] [Abstract][Full Text] [Related]
35. Biomarkers S100B and neuron-specific enolase predict outcome in hypothermia-treated encephalopathic newborns*.
Massaro AN; Chang T; Baumgart S; McCarter R; Nelson KB; Glass P
Pediatr Crit Care Med; 2014 Sep; 15(7):615-22. PubMed ID: 24777302
[TBL] [Abstract][Full Text] [Related]
36. Brain-Specific Serum Biomarkers Predict Neurological Morbidity in Diagnostically Diverse Pediatric Intensive Care Unit Patients.
Au AK; Bell MJ; Fink EL; Aneja RK; Kochanek PM; Clark RSB
Neurocrit Care; 2018 Feb; 28(1):26-34. PubMed ID: 28612133
[TBL] [Abstract][Full Text] [Related]
37. The associations between serum vascular endothelial growth factor, tumor necrosis factor and interleukin 4 with the markers of blood-brain barrier breakdown in patients with paraneoplastic neurological syndromes.
Michalak S; Kalinowska-Lyszczarz A; Rybacka-Mossakowska J; Zaborowski M; Kozubski W
J Neural Transm (Vienna); 2019 Feb; 126(2):149-158. PubMed ID: 30374596
[TBL] [Abstract][Full Text] [Related]
38. Postoperative course of S-100B protein and neuron-specific enolase in patients after implantation of continuous and pulsatile flow LVADs.
Potapov EV; Loebe M; Abdul-Khaliq H; Koster A; Stein J; Sodian R; Kopitz M; Hausmann H; Noon GP; DeBakey ME; Hetzer R
J Heart Lung Transplant; 2001 Dec; 20(12):1310-6. PubMed ID: 11744415
[TBL] [Abstract][Full Text] [Related]
39. [Clinical values of detection of serum levels of S100B and NSE in diagnosis of brain injuries at early period after cardiopulmonary bypass].
Gu XH; Zhang G; Zhang XQ; Song Y; Wang T; Li SX
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(14):975-7. PubMed ID: 17650423
[TBL] [Abstract][Full Text] [Related]
40. Level of S100B protein, neuron specific enolase, orexin A, adiponectin and insulin-like growth factor in serum of pediatric patients suffering from sleep disorders with or without epilepsy.
Kaciński M; Budziszewska B; Lasoń W; Zając A; Skowronek-Bała B; Leśkiewicz M; Kubik A; Basta-Kaim A
Pharmacol Rep; 2012; 64(6):1427-33. PubMed ID: 23406753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
